The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy ; volume:23 ; number:1 ; day:17 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
BMC neurology ; 23, Heft 1 (17.3.2023), 1-14, 12.2023
- Urheber
-
Yarlas, Aaron
Lovley, Andrew
Brown, Duncan
Vera-Llonch, Montserrat
Khella, Sami
Karam, Chafic
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-023-03116-7
- URN
-
urn:nbn:de:101:1-2023080521124847323426
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yarlas, Aaron
- Lovley, Andrew
- Brown, Duncan
- Vera-Llonch, Montserrat
- Khella, Sami
- Karam, Chafic
- SpringerLink (Online service)
Ähnliche Objekte (12)
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy
Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Hereditary transthyretin amyloidosis overview
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy
Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Hereditary transthyretin amyloidosis overview
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy
Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Hereditary transthyretin amyloidosis overview